vs
TriSalus Life Sciences, Inc.（TLSI）与VALUE LINE INC（VALU）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是VALUE LINE INC的1.6倍（$13.2M vs $8.3M），VALUE LINE INC净利率更高（71.4% vs -73.9%，领先145.3%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs -7.7%），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs -4.1%）
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
价值线公司是一家总部位于纽约的上市投资研究与金融出版企业，由阿诺德·伯恩哈德于1931年创立。该公司最为人熟知的业务是出版《价值线投资调查》，这份股票分析刊物跟踪覆盖约1700只上市个股的行情与研究。
TLSI vs VALU — 直观对比
营收规模更大
TLSI
是对方的1.6倍
$8.3M
营收增速更快
TLSI
高出67.6%
-7.7%
净利率更高
VALU
高出145.3%
-73.9%
两年增速更快
TLSI
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.2M | $8.3M |
| 净利润 | $-9.8M | $5.9M |
| 毛利率 | 86.7% | — |
| 营业利润率 | -24.8% | 12.1% |
| 净利率 | -73.9% | 71.4% |
| 营收同比 | 59.8% | -7.7% |
| 净利润同比 | 3.5% | 14.5% |
| 每股收益（稀释后） | $-0.22 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TLSIVALU
| Q1 26 | — | $8.3M | ||
| Q4 25 | $13.2M | $8.6M | ||
| Q3 25 | $11.6M | $8.6M | ||
| Q2 25 | $11.2M | $8.4M | ||
| Q1 25 | $9.2M | $9.0M | ||
| Q4 24 | $8.3M | $8.8M | ||
| Q3 24 | $7.3M | $8.9M | ||
| Q2 24 | $7.4M | $9.0M |
净利润TLSIVALU
| Q1 26 | — | $5.9M | ||
| Q4 25 | $-9.8M | $5.7M | ||
| Q3 25 | $-10.8M | $6.5M | ||
| Q2 25 | $-8.3M | $4.0M | ||
| Q1 25 | $-10.4M | $5.2M | ||
| Q4 24 | $-10.1M | $5.7M | ||
| Q3 24 | $-2.4M | $5.9M | ||
| Q2 24 | $-4.3M | $4.8M |
毛利率TLSIVALU
| Q1 26 | — | — | ||
| Q4 25 | 86.7% | — | ||
| Q3 25 | 83.5% | — | ||
| Q2 25 | 83.9% | — | ||
| Q1 25 | 83.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 86.3% | — | ||
| Q2 24 | 87.6% | — |
营业利润率TLSIVALU
| Q1 26 | — | 12.1% | ||
| Q4 25 | -24.8% | 17.7% | ||
| Q3 25 | -77.9% | 17.4% | ||
| Q2 25 | -65.4% | 9.9% | ||
| Q1 25 | -79.9% | 17.4% | ||
| Q4 24 | -91.8% | 19.7% | ||
| Q3 24 | -118.9% | 20.8% | ||
| Q2 24 | -111.0% | 16.5% |
净利率TLSIVALU
| Q1 26 | — | 71.4% | ||
| Q4 25 | -73.9% | 66.4% | ||
| Q3 25 | -93.5% | 75.1% | ||
| Q2 25 | -73.9% | 47.1% | ||
| Q1 25 | -113.2% | 57.6% | ||
| Q4 24 | -122.4% | 64.3% | ||
| Q3 24 | -32.6% | 66.3% | ||
| Q2 24 | -58.8% | 53.1% |
每股收益（稀释后）TLSIVALU
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | — | ||
| Q3 25 | $-0.96 | — | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.39 | — | ||
| Q4 24 | $-0.38 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.4M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-33.9M | $107.8M |
| 总资产 | $35.3M | $151.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TLSIVALU
| Q1 26 | — | $92.5M | ||
| Q4 25 | $20.4M | $86.6M | ||
| Q3 25 | $22.7M | $33.7M | ||
| Q2 25 | $26.5M | $67.7M | ||
| Q1 25 | $13.0M | $52.8M | ||
| Q4 24 | $8.5M | $22.3M | ||
| Q3 24 | $11.3M | $30.9M | ||
| Q2 24 | $16.5M | $4.4M |
股东权益TLSIVALU
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-33.9M | $105.5M | ||
| Q3 25 | $-26.7M | $103.0M | ||
| Q2 25 | $-19.4M | $99.7M | ||
| Q1 25 | $-34.4M | $99.0M | ||
| Q4 24 | $-25.9M | $96.7M | ||
| Q3 24 | $-20.4M | $93.9M | ||
| Q2 24 | $-25.3M | $90.8M |
总资产TLSIVALU
| Q1 26 | — | $151.0M | ||
| Q4 25 | $35.3M | $147.9M | ||
| Q3 25 | $36.5M | $148.2M | ||
| Q2 25 | $41.3M | $144.5M | ||
| Q1 25 | $28.6M | $143.6M | ||
| Q4 24 | $24.0M | $140.0M | ||
| Q3 24 | $27.5M | $138.6M | ||
| Q2 24 | $32.4M | $136.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $5.3M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | — |
| 自由现金流率自由现金流/营收 | -19.1% | — |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.89× |
| 过去12个月自由现金流最近4个季度 | $-19.1M | — |
8季度趋势，按日历期对齐
经营现金流TLSIVALU
| Q1 26 | — | $5.3M | ||
| Q4 25 | $-2.5M | $3.0M | ||
| Q3 25 | $-3.7M | $5.6M | ||
| Q2 25 | $-7.3M | $20.2M | ||
| Q1 25 | $-4.5M | $6.9M | ||
| Q4 24 | $-5.7M | $3.1M | ||
| Q3 24 | $-10.8M | $4.8M | ||
| Q2 24 | $-13.4M | $17.9M |
自由现金流TLSIVALU
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $-3.9M | — | ||
| Q2 25 | $-7.4M | $20.1M | ||
| Q1 25 | $-5.3M | $6.8M | ||
| Q4 24 | $-5.8M | $3.0M | ||
| Q3 24 | $-11.0M | $4.8M | ||
| Q2 24 | $-13.5M | $17.9M |
自由现金流率TLSIVALU
| Q1 26 | — | — | ||
| Q4 25 | -19.1% | — | ||
| Q3 25 | -33.9% | — | ||
| Q2 25 | -66.1% | 239.2% | ||
| Q1 25 | -57.3% | 75.3% | ||
| Q4 24 | -69.7% | 34.1% | ||
| Q3 24 | -149.9% | 53.7% | ||
| Q2 24 | -183.1% | 199.0% |
资本支出强度TLSIVALU
| Q1 26 | — | 0.0% | ||
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 1.9% | 0.0% | ||
| Q2 25 | 0.8% | 2.1% | ||
| Q1 25 | 8.2% | 1.2% | ||
| Q4 24 | 0.6% | 0.7% | ||
| Q3 24 | 2.3% | 0.0% | ||
| Q2 24 | 0.8% | 0.2% |
现金转化率TLSIVALU
| Q1 26 | — | 0.89× | ||
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 5.12× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 3.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
